Table 1.
Variable | Isthmus Group (n = 87) | Control Group (n = 87) | P value |
---|---|---|---|
Sex | |||
Male | 14 | 18 | 0.434 |
Female | 73 | 69 | |
Age | |||
<55 years | 58 | 53 | 0.430 |
≥55 years | 29 | 34 | |
Body mass index, kg/m2 | 25.4±4.1 | 25.1±3.8 | 0.617 |
Tumor size | |||
≤10 mm | 31 | 29 | 0.750 |
>10 mm | 56 | 58 | |
Capsular invasion, yes/no | 49/38 | 22/65 | <0.001 |
Extrathyroidal extension, yes/no | 19/68 | 11/76 | 0.108 |
Intraglandular dissemination, yes/no | 11/76 | 6/81 | 0.202 |
Concomitant thyroiditis, yes/no | 22/65 | 29/58 | 0.244 |
Pathologic subtype | |||
Classical | 59 | 54 | 0.427 |
Non-classical | 28 | 33 | |
BRAF gene mutation, yes/no | 65/22 | 61/26 | 0.497 |
pTNM stage, I/II/III/IV | 65/4/12/6 | 59/3/21/4 | 0.349 |
Notes: Values are n or mean ± standard deviation. Significant values are shown in bold.
Abbreviation: pTNM stage, pathologic TNM stage.